CDK 4/6 benefit extends into subsequent therapy.
A new study has found that this protein may be responsible for lower survival rates in patients with HER2+ breast cancer.
The evidence for chemo hasn't changed. Practice has.
When surgery isn't an option, what's the best second choice for RCC?
Can a new agent block tumor growth in kidney cancer?
A new algorithm could significantly eliminate unnecessary operations for breast cancer lesions by predicting which ones will become cancerous.
Schizophrenia and the incidence of breast cancer may be linked together.
Phase II Study Results Find Rituximab & Chemotherapy Combination Treatment Prolongs Survival in Patients With PCNSL
A new study finds that this standard combo therapy is safer and more beneficial than the latest pharmaceutical agents.
Patients with HL and NHL report physical burdens and "suboptimal" delivery of survivorship information and follow-up care.
Does the standard first-line treatment for PV increase risk of leukemia?
A new study found that breast implants are linked to an increased risk of this rare type of cancer.
A new international study found that night shift work significantly increases the risk of developing common cancers in women.
The U.S. Food and Drug Administration has approved the use of the intravenous drug TRISENOX (Teva Pharmaceutical Industries Ltd.) in combination with tretinoin for first line treatment of adult patients who have been newly-diagnosed with low-risk APL.
The U.S. Food and Drug Administration has approved a new breast cancer treatment machine that uses gamma rays to target tumors without harming healthy tissue.
The National Comprehensive Cancer Network has issued updated guidelines for Hodgkin lymphoma, which focus on the management of HL using existing treatments and the need for long-term follow-up after treatment completion.